Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Webinars

Don’t miss your chance to engage with industry thought-leaders on topics that matter in taking drugs from ideas to the clinic.

Upcoming Webinars


How can synthesis successfully align with modern drug discovery programmes?

Dr Andy Novak, Principal Scientist, Chemistry

Weds 30 June, 3pm (UK)

Synthesis of compounds suitable for biological evaluation is often the “rate determining step” for preclinical drug discovery programmes. We will discuss how to leverage different approaches to synthesis in order to drive success across multiple preclinical phases, including hit-2-lead and lead optimisation.

 

REGISTER FOR THIS WEBINAR


Past Webinars

Degraders on The Rise – Targeted Protein Degradation in Drug Discovery

VIEW WEBINAR

Psychedelics and Psychiatry: A Roadmap to Evaluate the Safety, Abuse Potential, and Efficacy of Psychedelics in Early Phase Drug Development

VIEW WEBINAR

A Tale of Two Libraries: How can complementary collections drive success in lead identification?

VIEW WEBINAR

Mouse Models of Cancer: understand their limitations to exploit their strengths

VIEW WEBINAR

To Control or be Controlled: Navigating the abuse potential evaluation of CNS-active drugs for EU and US submissions

VIEW WEBINAR

How DMPK should integrate with and influence projects in discovery and beyond

VIEW WEBINAR

Rethinking Diabetes Drug Discovery

VIEW WEBINAR

Can we improve oncology drug discovery?

VIEW WEBINAR

Can rodent kidney models really simulate the clinic?

VIEW WEBINAR

How to choose the best biophysical technique for your project

VIEW WEBINAR

Decision making in abuse potential assessments… are we getting it right?

VIEW WEBINAR

A journey through anti-inflammatory drug discovery

VIEW WEBINAR

How we created a world-leading HTS system

VIEW WEBINAR